DFPG Investments’s Biogen BIIB Stock Holding History

DFPG Investments’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-972	Closed	-$278K	–	165
2020 Q3	$278K	Buy	+972	New	+$271K	0.15%	133

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DFPG Investments's BIIB Position: Q4 2020 in Review

DFPG Investments sold out of Biogen (BIIB) in Q4 2020, closing a stake of 972 shares — an estimated $278K sold.

DFPG Investments first reported a position in BIIB in Q3 2020 and held it in 1 quarter. The position peaked at $278K in Q3 2020. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

DFPG Investments reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
DFPG Investments sold 972 Biogen shares in Q4 2020, an estimated $278K.
DFPG Investments first reported a position in Biogen in Q3 2020 and held it in 1 quarter.
DFPG Investments's Biogen position peaked at $278K in Q3 2020.
1,060 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on DFPG Investments's 13F filing for Q4 2020, filed 19 Jan 2021.